HL7 Europe Hospital Discharge Report, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/hdr/ and changes regularly. See the Directory of published versions
Copyright
IP statements
This publication includes IP covered under the following statements.
- The UCUM codes, UCUM table (regardless of format), and UCUM Specification are copyright 1999-2009, Regenstrief Institute, Inc. and the Unified Codes for Units of Measures (UCUM) Organization. All rights reserved. https://ucum.org/trac/wiki/TermsOfUse
Show Usage
- This material contains content from LOINC. LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc.
Show Usage
- This material contains content that is copyright of SNOMED International. Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact https://www.snomed.org/get-snomed or info@snomed.org.
Show Usage
- SNOMED Clinical Terms® (SNOMED CT®): AllergyIntolerance/penicillin-allergy, Bundle/HDR-Luigi-De-Luca-Example... Show 22 more, Bundle/HDR-Paolo-Marcheschi-Example, Bundle/HDR-Reijer-Wolff-Example, Bundle/bundle-swart, CarePlan/b84038f8-9541-4c5b-93b0-a7f1b8e55bd3, Condition/a5bf69e4-24db-48a8-9eda-71516dcaf1d9, ConditionHdrVS, Device/pacemaker-001, DeviceUseStatement/example-deviceusestatement-euhdr, DeviceUseStatementEuHdr, EncounterEuHdr, EncounterTypeHdrVS, FamilyMemberHistory/635c22e7-d7f1-45ad-9b4d-d4fe35239085, Flag/example-flag-allergy, Immunization/example-covid19-vax-admin, MedicalDevicesSnomedCtHdrVS, Medication/01A-Cefuroxime1500GenericExplicit, Medication/01C-Cefuroxime1500Branded, MedicationAdministration/1bcfb26f-6958-4604-a40b-712170c1e536, MedicationRequest/400C-prescription-cefuroxime-singleline, MedicationStatement/example-medicationstatement-euhdr, Observation/lab-swart-3 and Procedure/sectio-swart
- This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html
Show Usage
- AllergyIntolerance Clinical Status Codes: AllergyIntolerance/penicillin-allergy
- AllergyIntolerance Verification Status: AllergyIntolerance/penicillin-allergy
- Common Tags: MedicationRequest/400C-prescription-cefuroxime-singleline
- Condition Clinical Status Codes: Bundle/HDR-Luigi-De-Luca-Example, Bundle/HDR-Paolo-Marcheschi-Example, Bundle/HDR-Reijer-Wolff-Example, Bundle/bundle-swart and Condition/a5bf69e4-24db-48a8-9eda-71516dcaf1d9
- Flag Category: Flag/example-flag-allergy and Flag/example-flag-no-left-arm
- Observation Category Codes: Bundle/HDR-Luigi-De-Luca-Example, Bundle/bundle-swart, Observation/gewicht-swart and Observation/lab-swart-3
- identifierType: Bundle/HDR-Luigi-De-Luca-Example, Bundle/HDR-Paolo-Marcheschi-Example and Bundle/HDR-Reijer-Wolff-Example
- providerRole: Immunization/example-covid19-vax-admin and ImmunizationEuHdrObligation
- ActCode: Bundle/HDR-Luigi-De-Luca-Example, Bundle/HDR-Paolo-Marcheschi-Example... Show 5 more, Bundle/HDR-Reijer-Wolff-Example, Bundle/bundle-swart, Encounter/12fef60c-1fe7-4988-8286-af691889a3f3, EncounterClassHdrVS and EncounterEuHdr
- ActPriority: AdmissionUrgencyHdrVS and EncounterEuHdr
- MaritalStatus: Bundle/HDR-Paolo-Marcheschi-Example
- ParticipationType: EncounterEuHdr and EncounterEuHdrObligation
- RoleCode: Bundle/HDR-Luigi-De-Luca-Example and FamilyMemberHistory/635c22e7-d7f1-45ad-9b4d-d4fe35239085
- Unless otherwise indicated, reproduction of material posted on Council of Europe websites, and reproduction of photographs for which the Council of Europe holds copyright – see legal notice \“photo credits\” – is authorised for private use and for informational and educational uses relating to the Council of Europe’s work. This authorisation is subject to the condition that the source be indicated and no charge made for reproduction. Persons wishing to make some other use than those specified above, including commercial use, of information and text posted on these sites are asked to apply for prior written authorisation to the Council of Europe, Directorate of Communication.
Show Usage
